Qiang Chen

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 24

Top Venues

Nature structural & molecular biology

Nature communications

Blood cancer journal

Science advances

Sichuan University

Peking University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sichuan University Sep 01 2018

China

Professor :: State Key Laboratory of Biotherapy

Sichuan University Apr 01 2013 - Aug 31 2018

China

Associate Professor (Principal Investigator) :: State Key Laboratory of Biotherapy

Dana-Farber Cancer Institute

United States

Postdoc

Education History

Peking University

China

PHD :: School of Life Science

Peking University

China

BSC :: School of Life Science

Publications

Mengshi Hu, Tao Yang, Linyu Yang, Lu Niu, Jinbing Zhu, Ailin Zhao, Mingsong Shi, Xue Yuan, Minghai Tang, Jianhong Yang, Heying Pei, Zhuang Yang, Qiang Chen, Haoyu Ye, Ting Niu, Li-Juan Chen
Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F -induced myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Yuanyuan Li, Zhangfei Shen, Mengyuan Zhang, Xiao-Yuan Yang, Sean P Cleary, Jiale Xie, Ila A Marathe, Marius Kostelic, Jacelyn Greenwald, Anthony D Rish, Vicki H Wysocki, Chong Chen, Qiang Chen, Tian-Min Fu, Yamei Yu
PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defense. Nature structural & molecular biology (2024)
Yuanyuan Li, Zhangfei Shen, Mengyuan Zhang, Xiao-Yuan Yang, Sean P Cleary, Jiale Xie, Ila A Marathe, Marius Kostelic, Jacelyn Greenwald, Anthony D Rish, Vicki H Wysocki, Chong Chen, Qiang Chen, Tian-Min Fu, Yamei Yu
PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defense. Nature structural & molecular biology 31 (3) (2024)
Mengshi Hu, Tao Yang, Linyu Yang, Lu Niu, Jinbing Zhu, Ailin Zhao, Mingsong Shi, Xue Yuan, Minghai Tang, Jianhong Yang, Heying Pei, Zhuang Yang, Qiang Chen, Haoyu Ye, Ting Niu, Li-Juan Chen
Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F -induced myeloproliferative neoplasms. Blood cancer journal 14 (1) (2024)
Yuanyuan Li, Zhangfei Shen, Mengyuan Zhang, Xiao-Yuan Yang, Sean P Cleary, Jiale Xie, Ila A Marathe, Marius Kostelic, Jacelyn Greenwald, Anthony D Rish, Vicki H Wysocki, Chong Chen, Qiang Chen, Tian-Min Fu, Yamei Yu
PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defense. Nature structural & molecular biology 31 (3) (2024)
Yuanyuan Li, Zhangfei Shen, Mengyuan Zhang, Xiao-Yuan Yang, Sean P Cleary, Jiale Xie, Ila A Marathe, Marius Kostelic, Jacelyn Greenwald, Anthony D Rish, Vicki H Wysocki, Chong Chen, Qiang Chen, Tian-Min Fu, Yamei Yu
PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defense. Nature structural & molecular biology 31 (3) (2024)
Yuanyuan Li, Zhangfei Shen, Mengyuan Zhang, Xiao-Yuan Yang, Sean P Cleary, Jiale Xie, Ila A Marathe, Marius Kostelic, Jacelyn Greenwald, Anthony D Rish, Vicki H Wysocki, Chong Chen, Qiang Chen, Tian-Min Fu, Yamei Yu
PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defense. Nature structural & molecular biology 31 (3) (2024)
Yuanyuan Li, Zhangfei Shen, Mengyuan Zhang, Xiao-Yuan Yang, Sean P Cleary, Jiale Xie, Ila A Marathe, Marius Kostelic, Jacelyn Greenwald, Anthony D Rish, Vicki H Wysocki, Chong Chen, Qiang Chen, Tian-Min Fu, Yamei Yu
PtuA and PtuB assemble into an inflammasome-like oligomer for anti-phage defense. Nature structural & molecular biology 31 (3) (2024)
Weizhi Chen, Rui Liu, Yamei Yu, Dong-Qing Wei, Qiang Chen, Qin Xu
Molecular Mechanism of Mutational Disruption of DCLK1 Autoinhibition Provides a Rationale for Inhibitor Screening. International journal of molecular sciences 24 (18) (2023)
Jie Cheng, Yamei Yu, Xingyu Wang, Xi Zheng, Ting Liu, Daojun Hu, Yongfeng Jin, Ying Lai, Tian-Min Fu, Qiang Chen
Structural basis for the self-recognition of sDSCAM in Chelicerata. Nature communications 14 (1) (2023)
Jie Cheng, Yamei Yu, Xingyu Wang, Xi Zheng, Ting Liu, Daojun Hu, Yongfeng Jin, Ying Lai, Tian-Min Fu, Qiang Chen
Structural basis for the self-recognition of sDSCAM in Chelicerata. Nature communications 14 (1) (2023)
Jie Cheng, Yamei Yu, Xingyu Wang, Xi Zheng, Ting Liu, Daojun Hu, Yongfeng Jin, Ying Lai, Tian-Min Fu, Qiang Chen
Structural basis for the self-recognition of sDSCAM in Chelicerata. Nature communications 14 (1) (2023)
Jie Cheng, Yamei Yu, Xingyu Wang, Xi Zheng, Ting Liu, Daojun Hu, Yongfeng Jin, Ying Lai, Tian-Min Fu, Qiang Chen
Structural basis for the self-recognition of sDSCAM in Chelicerata. Nature communications 14 (1) (2023)
Lifang Xie, Yun Hu, Li Li, Lurong Jiang, Yaoge Jiao, Yanhong Wang, Lifang Zhou, Rui Tao, Junyan Qu, Qiang Chen, Shaohua Yao
Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non-PI domain mutations derived from xCas9. The FEBS journal 289 (19) (2022)
Mengshi Hu, Tao Yang, Linyu Yang, Lu Niu, Jinbing Zhu, Ailin Zhao, Mingsong Shi, Xue Yuan, Minghai Tang, Jianhong Yang, Heying Pei, Zhuang Yang, Qiang Chen, Haoyu Ye, Ting Niu, Li-Juan Chen
Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F -induced myeloproliferative neoplasms. Blood cancer journal 12 (3) (2022)
Rui Tao, Yanhong Wang, Yun Hu, Yaoge Jiao, Lifang Zhou, Lurong Jiang, Li Li, Xingyu He, Min Li, Yamei Yu, Qiang Chen, Shaohua Yao
WT-PE: Prime editing with nuclease wild-type Cas9 enables versatile large-scale genome editing. Signal transduction and targeted therapy 7 (1) (2022)
Rui Tao, Yanhong Wang, Yaoge Jiao, Yun Hu, Li Li, Lurong Jiang, Lifang Zhou, Junyan Qu, Qiang Chen, Shaohua Yao
Bi-PE: bi-directional priming improves CRISPR/Cas9 prime editing in mammalian cells. Nucleic acids research 50 (11) (2022)
Jianhong Yang, Yamei Yu, Yong Li, Wei Yan, Haoyu Ye, Lu Niu, Minghai Tang, Zhoufeng Wang, Zhuang Yang, Heying Pei, Haoche Wei, Min Zhao, Jiaolin Wen, Linyu Yang, Liang Ouyang, Yuquan Wei, Qiang Chen, Wei-Min Li, Li-Juan Chen
Cevipabulin-tubulin complex reveals a novel agent binding site on α-tubulin with tubulin degradation effect. Science advances 7 (21) (2021)
Yuanyuan Li, Jiazhen Yang, Lu Niu, Daojun Hu, Huijuan Li, Lijuan Chen, Yamei Yu, Qiang Chen
Structural insights into the design of indole derivatives as tubulin polymerization inhibitors. FEBS letters 594 (1) (2019)
Ting Zeng, Zeping Zuo, Youfu Luo, Yinglan Zhao, Yamei Yu, Qiang Chen
A novel series of human dihydroorotate dehydrogenase inhibitors discovered by in vitro screening: inhibition activity and crystallographic binding mode. FEBS open bio 9 (8) (2019)
Yuxi Wang, Yamei Yu, Guo-Bo Li, Shu-Ang Li, Chengyong Wu, Benoît Gigant, Wenming Qin, Hao Chen, Yangping Wu, Qiang Chen, Jinliang Yang
Mechanism of microtubule stabilization by taccalonolide AJ. Nature communications 8 (2017)
Sha Liu, Sen Ji, Zhu-Jun Yu, Hua-Li Wang, Xu Cheng, Wei-Jian Li, Li Jing, Yamei Yu, Qiang Chen, Ling-Ling Yang, Guo-Bo Li, Yong Wu
Structure-based discovery of new selective small-molecule sirtuin 5 inhibitors. Chemical biology & drug design 91 (1) (2017)
Jianhong Yang, Yuxi Wang, Taijing Wang, Jian Jiang, Catherine H Botting, Huanting Liu, Qiang Chen, Jinliang Yang, James H Naismith, Xiaofeng Zhu, Lijuan Chen
Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule. Nature communications 7 (2016)
Shu-Ang Li, Linna Cheng, Yamei Yu, Jia-Huai Wang, Qiang Chen
Structural basis of Dscam1 homodimerization: Insights into context constraint for protein recognition. Science advances 2 (5) (2016)

Qiang Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qiang Chen